CALQUENCE ® (acalabrutinib) plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial Read more
Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with primary biliary cholangitis Read more
New report: For-profit clinics expanded by Ford government charging patients thousands in unlawful fees Read more
Some cancer patients can find it hard to tell family and friends about their diagnosis: ‘You’re dealing with this all alone’ Read more
Bringing confident diagnosis to more patients at low cost: Philips launches new AI-enabled CT 5300 at #ECR2024 Read more
Exclusive-Eisai expects 1,500 Alzheimer’s patients in China launch, sees ‘huge’ growth By Reuters Read more
White patients are more likely than Black patients to be prescribed opioids for pain in US emergency departments Read more